Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 852654 | ISIN: US8825081040 | Ticker-Symbol: TII
Tradegate
24.01.25
18:41 Uhr
177,86 Euro
-14,64
-7,61 %
1-Jahres-Chart
TEXAS INSTRUMENTS INC Chart 1 Jahr
5-Tage-Chart
TEXAS INSTRUMENTS INC 5-Tage-Chart
RealtimeGeldBriefZeit
177,34177,7218:42
177,32177,7618:42
PR Newswire
78 Leser
Artikel bewerten:
(0)

Texas Instruments Incorporated: TI reports Q4 2024 and 2024 financial results and shareholder returns

Finanznachrichten News

DALLAS, Jan. 23, 2025 /PRNewswire/ -- Texas Instruments Incorporated (TI) (Nasdaq: TXN) today reported fourth quarter revenue of $4.01 billion, net income of $1.21 billion and earnings per share of $1.30. Earnings per share included a 2-cent benefit that was not in the company's original guidance.

Regarding the company's performance and returns to shareholders, Haviv Ilan, TI's president and CEO, made the following comments:

  • "Revenue decreased 3% sequentially and 2% from the same quarter a year ago.
  • "Our cash flow from operations of $6.3 billion for the trailing 12 months again underscored the strength of our business model, the quality of our product portfolio and the benefit of 300mm production. Free cash flow for the same period was $1.5 billion.
  • "Over the past 12 months we invested $3.8 billion in R&D and SG&A, invested $4.8 billion in capital expenditures and returned $5.7 billion to owners.
  • "TI's first quarter outlook is for revenue in the range of $3.74 billion to $4.06 billion and earnings per share between $0.94 and $1.16. We now expect our 2025 effective tax rate to be about 12%."

Free cash flow, a non-GAAP financial measure, is cash flow from operations less capital expenditures.

Earnings summary

(In millions, except per-share amounts)


Q4 2024


Q4 2023


Change

Revenue


$

4,007


$

4,077


(2) %

Operating profit


$

1,377


$

1,533


(10) %

Net income


$

1,205


$

1,371


(12) %

Earnings per share


$

1.30


$

1.49


(13) %

Cash generation






Trailing 12 Months

(In millions)


Q4 2024


Q4 2024


Q4 2023


Change

Cash flow from operations


$

1,998


$

6,318


$

6,420


(2) %

Capital expenditures


$

1,192


$

4,820


$

5,071


(5) %

Free cash flow


$

806


$

1,498


$

1,349


11 %

Free cash flow % of revenue






9.6 %



7.7 %



Cash return






Trailing 12 Months

(In millions)


Q4 2024


Q4 2024


Q4 2023


Change

Dividends paid


$

1,240


$

4,795


$

4,557


5 %

Stock repurchases


$

537


$

929


$

293


217 %

Total cash returned


$

1,777


$

5,724


$

4,850


18 %

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES


Consolidated Statements of Income


For Three Months Ended

December 31,


For Years Ended

December 31,

(In millions, except per-share amounts)


2024


2023


2024


2023

Revenue


$

4,007


$

4,077


$

15,641


$

17,519

Cost of revenue (COR)



1,693



1,646



6,547



6,500

Gross profit



2,314



2,431



9,094



11,019

Research and development (R&D)



491



460



1,959



1,863

Selling, general and administrative (SG&A)



446



438



1,794



1,825

Restructuring charges/other



-



-



(124)



-

Operating profit



1,377



1,533



5,465



7,331

Other income (expense), net (OI&E)



112



113



496



440

Interest and debt expense



130



98



508



353

Income before income taxes



1,359



1,548



5,453



7,418

Provision for income taxes



154



177



654



908

Net income


$

1,205


$

1,371


$

4,799


$

6,510














Diluted earnings per common share


$

1.30


$

1.49


$

5.20


$

7.07














Average shares outstanding:













Basic



912



908



912



908

Diluted



919



915



919



916














Cash dividends declared per common share


$

1.36


$

1.30


$

5.26


$

5.02














Supplemental Information








Provision for income taxes is based on the following:







Operating taxes (calculated using the estimated annual effective tax rate)


$

170


$

180


$

743


$

974

Discrete tax items



(16)



(3)



(89)



(66)

Provision for income taxes (effective taxes)


$

154


$

177


$

654


$

908














A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend equivalents. Diluted EPS

is calculated using the following:

Net income


$

1,205


$

1,371


$

4,799


$

6,510

Income allocated to RSUs



(7)



(7)



(24)



(33)

Income allocated to common stock for diluted EPS


$

1,198


$

1,364


$

4,775


$

6,477

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES


Consolidated Balance Sheets


December 31,

(In millions, except par value)


2024


2023

Assets







Current assets:







Cash and cash equivalents


$

3,200


$

2,964

Short-term investments



4,380



5,611

Accounts receivable, net of allowances of ($21) and ($16)



1,719



1,787

Raw materials



395



420

Work in process



2,214



2,109

Finished goods



1,918



1,470

Inventories



4,527



3,999

Prepaid expenses and other current assets



1,200



761

Total current assets



15,026



15,122

Property, plant and equipment at cost



15,254



13,268

Accumulated depreciation



(3,907)



(3,269)

Property, plant and equipment



11,347



9,999

Goodwill



4,362



4,362

Deferred tax assets



936



757

Capitalized software licenses



257



223

Overfunded retirement plans



233



173

Other long-term assets



3,348



1,712

Total assets


$

35,509


$

32,348








Liabilities and stockholders' equity







Current liabilities:







Current portion of long-term debt


$

750


$

599

Accounts payable



820



802

Accrued compensation



839



836

Income taxes payable



159



172

Accrued expenses and other liabilities



1,075



911

Total current liabilities



3,643



3,320

Long-term debt



12,846



10,624

Underfunded retirement plans



110



108

Deferred tax liabilities



53



63

Other long-term liabilities



1,954



1,336

Total liabilities



18,606



15,451

Stockholders' equity:







Preferred stock, $25 par value. Shares authorized - 10; none issued



-



-

Common stock, $1 par value. Shares authorized - 2,400; shares issued - 1,741



1,741



1,741

Paid-in capital



3,935



3,362

Retained earnings



52,262



52,283

Treasury common stock at cost







Shares: 2024 - 830; 2023 - 832



(40,895)



(40,284)

Accumulated other comprehensive income (loss), net of taxes (AOCI)



(140)



(205)

Total stockholders' equity



16,903



16,897

Total liabilities and stockholders' equity


$

35,509


$

32,348

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES


Consolidated Statements of Cash Flows


For Three Months Ended

December 31,


For Years Ended

December 31,

(In millions)


2024


2023


2024


2023

Cash flows from operating activities













Net income


$

1,205


$

1,371


$

4,799


$

6,510

Adjustments to net income:













Depreciation



416



322



1,508



1,175

Amortization of capitalized software



19



15



72



63

Stock compensation



78



68



387



362

(Gains) losses on sales of assets



(1)



1



(127)



-

Deferred taxes



(21)



(140)



(210)



(299)

Increase (decrease) from changes in:













Accounts receivable



143



189



68



108

Inventories



(231)



(91)



(528)



(1,242)

Prepaid expenses and other current assets



76



8



7



46

Accounts payable and accrued expenses



87



(10)



125



(33)

Accrued compensation



115



126



(12)



29

Income taxes payable



110



58



597



(7)

Changes in funded status of retirement plans



31



(4)



33



45

Other



(29)



11



(401)



(337)

Cash flows from operating activities



1,998



1,924



6,318



6,420














Cash flows from investing activities













Capital expenditures



(1,192)



(1,148)



(4,820)



(5,071)

Proceeds from asset sales



1



-



195



3

Purchases of short-term investments



(909)



(2,565)



(9,716)



(12,705)

Proceeds from short-term investments



2,726



3,411



11,187



13,387

Other



(12)



(9)



(48)



24

Cash flows from investing activities



614



(311)



(3,202)



(4,362)














Cash flows from financing activities













Proceeds from issuance of long-term debt



-



-



2,980



3,000

Repayment of debt



(300)



-



(600)



(500)

Dividends paid



(1,240)



(1,181)



(4,795)



(4,557)

Stock repurchases



(537)



(65)



(929)



(293)

Proceeds from common stock transactions



87



45



517



263

Other



(11)



(14)



(53)



(57)

Cash flows from financing activities



(2,001)



(1,215)



(2,880)



(2,144)














Net change in cash and cash equivalents



611



398



236



(86)

Cash and cash equivalents at beginning of period



2,589



2,566



2,964



3,050

Cash and cash equivalents at end of period


$

3,200


$

2,964


$

3,200


$

2,964














Supplemental cash flow information













Investment tax credit (ITC) used to reduce income taxes payable


$

56


$

-


$

588


$

-

Total cash benefit related to the U.S. CHIPS and Science Act


$

56


$

-


$

588


$

-

Quarterly segment results

(In millions)


Q4 2024


Q4 2023


Change

Analog:









Revenue


$

3,174


$

3,120


2 %

Operating profit


$

1,237


$

1,280


(3) %

Embedded Processing:









Revenue


$

613


$

752


(18) %

Operating profit


$

58


$

195


(70) %

Other:









Revenue


$

220


$

205


7 %

Operating profit*


$

82


$

58


41 %


* Includes restructuring charges/other.

Annual segment results

(In millions)


2024


2023


Change

Analog:









Revenue


$

12,161


$

13,040


(7) %

Operating profit


$

4,608


$

5,821


(21) %

Embedded Processing:









Revenue


$

2,533


$

3,368


(25) %

Operating profit


$

352


$

1,008


(65) %

Other:









Revenue


$

947


$

1,111


(15) %

Operating profit*


$

505


$

502


1 %


* Includes restructuring charges/other.

Non-GAAP financial information

This release includes references to free cash flow and ratios based on that measure. These are financial measures that were not prepared in accordance with GAAP. Free cash flow was calculated by subtracting capital expenditures from the most directly comparable GAAP measure, cash flows from operating activities (also referred to as cash flow from operations).

We believe that free cash flow and the associated ratios provide insight into our liquidity, our cash-generating capability and the amount of cash potentially available to return to shareholders, as well as insight into our financial performance. These non-GAAP measures are supplemental to the comparable GAAP measures.

Reconciliation to the most directly comparable GAAP measures is provided in the table below.



For Years Ended

December 31,



(In millions)


2024


2023


Change

Cash flow from operations (GAAP)*


$

6,318


$

6,420


(2) %

Capital expenditures



(4,820)



(5,071)



Free cash flow (non-GAAP)


$

1,498


$

1,349


11 %










Revenue


$

15,641


$

17,519












Cash flow from operations as a percentage of revenue (GAAP)



40.4 %



36.6 %



Free cash flow as a percentage of revenue (non-GAAP)



9.6 %



7.7 %




* Includes a cash benefit of $588 million from the U.S. CHIPS and Science Act ITC used to reduce income taxes

payable for 2024.

This release also includes references to operating taxes, a non-GAAP term we use to describe taxes calculated using the estimated annual effective tax rate, a GAAP measure that by definition does not include discrete tax items. We believe the term operating taxes helps to differentiate from effective taxes, which include discrete tax items.

Notice regarding forward-looking statements

This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as TI or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe TI's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

We urge you to carefully consider the following important factors that could cause actual results to differ materially from the expectations of TI or our management:

  • Economic, social and political conditions, and natural events in the countries in which we, our customers or our suppliers operate, including global trade policies;
  • Market demand for semiconductors, particularly in the industrial and automotive markets, and customer demand that differs from forecasts;
  • Our ability to compete in products and prices in an intensely competitive industry;
  • Evolving cybersecurity and other threats relating to our information technology systems or those of our customers, suppliers and other third parties;
  • Our ability to successfully implement and realize opportunities from strategic, business and organizational changes, or our ability to realize our expectations regarding the amount and timing of associated restructuring charges and cost savings;
  • Our ability to develop, manufacture and market innovative products in a rapidly changing technological environment, our timely implementation of new manufacturing technologies and installation of manufacturing equipment, and our ability to realize expected returns on significant investments in manufacturing capacity;
  • Availability and cost of key materials, utilities, manufacturing equipment, third-party manufacturing services and manufacturing technology;
  • Our ability to recruit and retain skilled personnel and effectively manage key employee succession;
  • Product liability, warranty or other claims relating to our products, software, manufacturing, delivery, services, design or communications, or recalls by our customers for a product containing one of our parts;
  • Compliance with or changes in the complex laws, rules and regulations to which we are or may become subject, or actions of enforcement authorities, that restrict our ability to operate our business or subject us to fines, penalties or other legal liability;
  • Changes in tax law and accounting standards that impact the tax rate applicable to us, the jurisdictions in which profits are determined to be earned and taxed, adverse resolution of tax audits, increases in tariff rates, and the ability to realize deferred tax assets;
  • Financial difficulties of our distributors or semiconductor distributors' promotion of competing product lines to our detriment; or disputes with current or former distributors;
  • Losses or curtailments of purchases from key customers or the timing and amount of customer inventory adjustments;
  • Our ability to maintain or improve profit margins, including our ability to utilize our manufacturing facilities at sufficient levels to cover our fixed operating costs, in an intensely competitive and cyclical industry and changing regulatory environment;
  • Our ability to maintain and enforce a strong intellectual property portfolio and maintain freedom of operation in all jurisdictions where we conduct business; or our exposure to infringement claims;
  • Instability in the global credit and financial markets; and
  • Impairments of our non-financial assets.

For a more detailed discussion of these factors, see the Risk factors discussion in Item 1A of TI's most recent Form 10-K. The forward-looking statements included in this release are made only as of the date of this release, and we undertake no obligation to update the forward-looking statements to reflect subsequent events or circumstances. If we do update any forward-looking statement, you should not infer that we will make additional updates with respect to that statement or any other forward-looking statement.

About Texas Instruments

Texas Instruments Incorporated (Nasdaq: TXN) is a global semiconductor company that designs, manufactures and sells analog and embedded processing chips for markets such as industrial, automotive, personal electronics, communications equipment and enterprise systems. At our core, we have a passion to create a better world by making electronics more affordable through semiconductors. This passion is alive today as each generation of innovation builds upon the last to make our technology more reliable, more affordable and lower power, making it possible for semiconductors to go into electronics everywhere. Learn more at TI.com.

TXN-G

SOURCE Texas Instruments Incorporated

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.